Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating

Behavioural Activation in Social IsoLation (BASIL-C19): A pilot randomised controlled trial of a behavioural activation intervention to mitigate depression and loneliness in older adults with long-term health conditions during the Covid-19 pandemic

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN94091479

Enrollment

100

Registered

2020-06-09

Start date

2020-06-15

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and loneliness in older adults with long-term physical health conditions Mental and Behavioural Disorders

Interventions

Participants will be randomly allocated 1:1 to either the behavioural activation intervention group or the usual care with signposting information group. Active intervention: Behavioural Activation

such activities may benefit their physical and emotional wellbeing by helping people to stay connected with the world and remain active. The practitioner (support worker) and participant work together

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Older adults aged 65 years or over 2. Two or more long term physical health conditions

Exclusion criteria

Exclusion criteria: Older adults who: 1. Have cognitive impairment 2. Have bipolar disorder/psychosis/psychotic symptoms 3. Have alcohol or drug dependence 4. Are in the palliative phase of illness 5. Have active suicidal ideation 6. Are currently receiving psychological therapy 7. Are unable to speak or understand English

Design outcomes

Primary

Measure	Time frame
Self-reported depression severity (as measured by the Patient Health Questionnaire 9) at 1 month post-randomisation	—

Secondary

Measure	Time frame
At 1, 3 and 12 months post-randomisation (unless otherwise stated): 1. Depression (PHQ9) at 3 and 12 months post-randomisation 2. Anxiety (GAD-7) 3. Loneliness (De Jong Gierveld Scale - 11 items) 4. Health Related Quality of Life (SF-12v2) 5. A brief bespoke questionnaire will be used to collect health service use data at all study time-points (baseline and 1, 3 and 12 months post-randomisation) 6. In addition, we will capture estimates of rates of recruitment; randomisation; retention, intervention delivery and engagement. These will be described using a standard CONSORT flow diagram, and these will provide estimates to enable the design of a fully powered BASIL trial	—

Measure

Time frame

At 1, 3 and 12 months post-randomisation (unless otherwise stated): 1. Depression (PHQ9) at 3 and 12 months post-randomisation 2. Anxiety (GAD-7) 3. Loneliness (De Jong Gierveld Scale - 11 items) 4. Health Related Quality of Life (SF-12v2) 5. A brief bespoke questionnaire will be used to collect health service use data at all study time-points (baseline and 1, 3 and 12 months post-randomisation) 6. In addition, we will capture estimates of rates of recruitment; randomisation; retention, intervention delivery and engagement. These will be described using a standard CONSORT flow diagram, and these will provide estimates to enable the design of a fully powered BASIL trial

—

Countries

England, United Kingdom

Contacts

Public ContactLiz Littlewood

liz.littlewood@york.ac.uk+44 (0)1904 321828

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 14, 2026